EVALUATION OF BIODEGRADABLE NANOCARRIERS FOR TARGETED DRUG DELIVERY IN HEPATOCELLULAR CARCINOMA. Frontier in Medical and Health Research, [S. l.], v. 3, n. 7, p. 1259–1272, 2025. Disponível em: https://fmhr.net/index.php/fmhr/article/view/1225.. Acesso em: 23 apr. 2026.